Table 2.
Patient profiles
| Age (years) | Sex | Primary tumor type | Revised Tokuhashi score | Complication | Survival period (month) | Preoperative Frankel scorea | Postoperative Frankel scorea | Initial stageb | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General condition | Extraspinal bone metastases | Vertebral metastases | Internal organ | Primary site | Palsy | Tokuhashi score | |||||||||
| LK | |||||||||||||||
| 1 | 78 | f | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 9 | C | D | 3 | |
| 2 | 81 | f | Lung | 0 | 2 | 1 | 2 | 0 | 1 | 6 | 35 | C | D | 4 | |
| 3 | 87 | f | Lung | 0 | 2 | 2 | 0 | 0 | 1 | 5 | 4 | C | D | 1 | |
| 4 | 72 | m | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 3 | C | D | 4 | |
| 5 | 60 | f | Lung | 1 | 2 | 1 | 2 | 0 | 1 | 7 | 26 | D | D | 4 | |
| 6 | 86 | f | Lung | 0 | 2 | 0 | 2 | 0 | 1 | 5 | 12 | C | D | 4 | |
| 7 | 82 | m | Lung | 0 | 1 | 0 | 0 | 0 | 0 | 1 | infection | 1 | A | A | 3 |
| 8 | 72 | m | Lung | 0 | 1 | 2 | 2 | 0 | 1 | 6 | 3 | C | C | 4 | |
| 9 | 65 | m | Lung | 1 | 2 | 0 | 0 | 0 | 1 | 4 | 8 | C | D | 4 | |
| 10 | 69 | f | Lung | 0 | 1 | 0 | 2 | 0 | 1 | 4 | 7 | C | D | 4 | |
| Average | 75.2 ± 9.1 | 0.2 ± 0.4 | 1.7 ± 0.5 | 0.6 ± 0.8 | 1.4 ± 1.0 | 0 | 0.9 ± 0.3 | 4.8 ± 1.6 | 10.8 ± 11.1 | ||||||
| PB | |||||||||||||||
| 11 | 76 | m | Prostate | 0 | 2 | 2 | 2 | 5 | 1 | 12 | 62 | C | D | 4 | |
| 12 | 74 | m | Prostate | 1 | 2 | 1 | 2 | 5 | 1 | 12 | 11 | D | D | 3 | |
| 13 | 68 | m | Thyroid | 1 | 2 | 2 | 2 | 5 | 1 | 13 | 53 | D | D | 4 | |
| 14 | 84 | f | Breast | 0 | 2 | 1 | 2 | 5 | 1 | 11 | 44 | C | D | 1 | |
| 15 | 55 | f | Breast | 1 | 0 | 2 | 2 | 5 | 1 | 11 | 40 | D | D | 4 | |
| 16 | 70 | m | Prostate | 0 | 1 | 2 | 2 | 5 | 0 | 10 | 24 | B | D | 4 | |
| 17 | 72 | m | Prostate | 1 | 2 | 0 | 2 | 5 | 1 | 11 | infection | 27 | D | D | 4 |
| 18 | 66 | f | Thyroid | 1 | 2 | 1 | 2 | 5 | 1 | 12 | 26 | D | D | 4 | |
| 19 | 88 | m | Prostate | 0 | 2 | 0 | 2 | 5 | 0 | 9 | 10 | A | A | 4 | |
| 20 | 62 | f | Breast | 2 | 2 | 2 | 2 | 5 | 1 | 14 | 26 | D | D | 4 | |
| 21 | 58 | m | Prostate | 0 | 2 | 0 | 0 | 5 | 1 | 8 | 3 | C | D | 4 | |
| 22 | 73 | m | Prostate | 0 | 1 | 0 | 2 | 5 | 1 | 9 | 5 | C | D | 4 | |
| Average | 70.5 ± 9.7 | 0.6 ± 0.7 | 1.7 ± 0.7 | 1.1 ± 0.9 | 1.8 ± 0.6 | 5 | 0.8 ± 0.4 | 11.0 ± 1.8 | 27.6 ± 19.0 | ||||||
| OT | |||||||||||||||
| 23 | 71 | f | Rectum | 0 | 2 | 2 | 0 | 4 | 1 | 9 | 19 | D | D | 2 | |
| 24 | 76 | m | Kidney | 0 | 2 | 2 | 2 | 3 | 1 | 10 | 8 | D | D | 1 | |
| 25 | 71 | m | Kidney | 0 | 2 | 0 | 0 | 3 | 1 | 6 | 7 | C | D | 4 | |
| 26 | 83 | m | Rhabdomyosarcoma | 0 | 2 | 2 | 2 | 2 | 1 | 9 | 3 | C | C | 4 | |
| 27 | 78 | m | Kidney | 0 | 2 | 0 | 2 | 3 | 1 | 8 | infection | 5 | C | C | 4 |
| 28 | 87 | m | Unknown | 0 | 2 | 2 | 2 | 1 | 1 | 8 | 8 | C | D | 4 | |
| 29 | 62 | m | Colon | 0 | 2 | 0 | 0 | 2 | 1 | 5 | 2 | C | C | 4 | |
| 30 | 70 | m | Colon | 0 | 1 | 1 | 0 | 2 | 1 | 5 | 10 | D | D | 3 | |
| 31 | 79 | f | Multiple myeloma | 0 | 2 | 0 | 2 | 2 | 1 | 7 | 9 | C | C | 4 | |
| Average | 75.2 ± 7.6 | 0 | 1.9 ± 0.3 | 1.0 ± 1.0 | 1.1 ± 1.1 | 2.4 ± 0.9 | 1 | 7.4 ± 1.8 | 7.9 ± 5.0 | ||||||
LK lung cancer group, PB prostate, breast, or thyroid cancer group, OT other cancers group, m male, f female
aFrankel scores: A, complete neurological injury; B, preserved sensation only; C, preserved motor, nonfunctional; D, preserved motor, functional; E, normal (no neurological injury)
bInitial stage: 1, localized; 2, early locally advanced; 3, late locally advanced; 4, metastasized